Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
- Vriesendorp, Pieter A
- Schinkel, Arend F L
- Van Cleemput, Johan
- Willems, Rik
- Jordaens, Luc J L M
- Theuns, Dominic A M J
- van Slegtenhorst, Marjon A
- de Ravel de l'Argentière, Thomy
- Ten Cate, Folkert J
- Michels, Michelle
Publication date
September 2013
DOI Publisher
Elsevier ISSN
0002-8703 Journal
issn:0002-8703 Citation count (estimate)
40Abstract
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM), but this can be prevented by an implantable cardioverter-defibrillator (ICD). The aim of this study is to evaluate HCM patients with ICDs for primary or secondary prevention of SCD.status: publishe
Add to ORKG